Review of fractional epidemic models
The global impact of corona virus (COVID-19) has been profound, and the public health
threat it represents is the most serious seen in a respiratory virus since the 1918 influenza A …
threat it represents is the most serious seen in a respiratory virus since the 1918 influenza A …
How does HIV cause AIDS?
RA Weiss - Science, 1993 - science.org
Many questions have been posed about acquired immunodeficiency syndrome (AIDS)
pathogenesis. Is human immunodeficiency virus (HIV) both necessary and sufficient to …
pathogenesis. Is human immunodeficiency virus (HIV) both necessary and sufficient to …
Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site
NM Karp - US Patent 7,718,180, 2010 - Google Patents
The present invention relates to an immunogenic composi tion. More particularly, the
present invention is a composition directed to eliciting an immune response to at least one …
present invention is a composition directed to eliciting an immune response to at least one …
[图书][B] How to have theory in an epidemic: Cultural chronicles of AIDS
PA Treichler - 2020 - degruyter.com
Paula A. Treichler has become a singularly important voice among the significant theorists
on the AIDS crisis. Dissecting the cultural politics surrounding representations of HIV and …
on the AIDS crisis. Dissecting the cultural politics surrounding representations of HIV and …
HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy
JM Coffin - Science, 1995 - science.org
Several recent reports indicate that the long, clinically latent phase that characterizes human
immunodeficiency virus (HIV) infection of humans is not a period of viral inactivity, but an …
immunodeficiency virus (HIV) infection of humans is not a period of viral inactivity, but an …
Social regulation of gene expression in human leukocytes
SW Cole, LC Hawkley, JM Arevalo, CY Sung, RM Rose… - Genome biology, 2007 - Springer
Background Social environmental influences on human health are well established in the
epidemiology literature, but their functional genomic mechanisms are unclear. The present …
epidemiology literature, but their functional genomic mechanisms are unclear. The present …
Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase
LM Mansky, HM Temin - Journal of virology, 1995 - Am Soc Microbiol
The level of genetic variation of human immunodeficiency virus type 1 (HIV-1), a member of
the lentivirus genus of the Retroviridae family, is high relative to that of retroviruses in some …
the lentivirus genus of the Retroviridae family, is high relative to that of retroviruses in some …
[PDF][PDF] Nano and microparticles as controlled drug delivery devices
M Kumar - J. Pharm. Pharm. Sci, 2000 - ualberta.ca
Although, the drug delivery system (DDS) concept is not new, great progress has recently
been made in the treatment of a variety of diseases. Targeting delivery of drugs to the …
been made in the treatment of a variety of diseases. Targeting delivery of drugs to the …
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection
RAJ Shankarappa, JB Margolick, SJ Gange… - Journal of …, 1999 - Am Soc Microbiol
To understand the high variability of the asymptomatic interval between primary human
immunodeficiency virus type 1 (HIV-1) infection and the development of AIDS, we studied …
immunodeficiency virus type 1 (HIV-1) infection and the development of AIDS, we studied …
New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma
S Palmer, AP Wiegand, F Maldarelli… - Journal of clinical …, 2003 - Am Soc Microbiol
More sensitive assays for human immunodeficiency virus type 1 (HIV-1) RNA are needed to
detect, quantify, and characterize persistent viremia in patients who are receiving …
detect, quantify, and characterize persistent viremia in patients who are receiving …